Newsletter | May 26, 2026

05.26.26 -- STREAM Cutting-Edge Solutions In Cell, Gene, And Biologics Development

Going Beyond Traditional Contract Manufacturing In Pharma

Video | West Pharmaceutical Services, Inc.

Successfully advancing a drug-delivery device to market demands more than technical expertise; it requires coordinated execution, regulatory insight, and the ability to scale without disruption.

Flexible Therapeutic Development: Balancing Speed, Cost, And Process

Webinar | KBI Biopharma

Microbial development for first‑in‑human studies requires coordinated cell line, fermentation, and purification strategies to accelerate timelines while controlling cost and process robustness.

3D Screen Printing: Breakthrough Solutions For Patient-Centric Therapies

Webinar | Adare Pharma Solutions

Explore 3D screen printing’s potential to revolutionize pharmaceutical manufacturing with scalable, customizable, multi-drug tablets and precise, patient-centric drug release profiles.

Strengthening Global Capacity For Biologics Manufacturing

Video | AGC Biologics

Michael Brotz provides an in-depth look at our Seattle site and the unique capabilities of the facility, including its single-use and stainless-steel capacity, new manufacturing lines, and more.

Navigating The Analytical Testing Bottleneck

Video | Outsourced Pharma

This segment of the Outsourced Pharma Live event, "One Program Many CDMOs: Managing Multi-Partner Strategies," addresses the analytical bottlenecks that arise when testing methods are distributed across multiple geographic partners.

A Fully Integrated CDMO Partner For The Global Pharmaceutical Industry

Video | Asymchem

Smarter chemistry and process design enable sustainable manufacturing. Modern methods reduce waste and energy use while maintaining efficiency and high‑quality pharmaceutical production.

SPONSOR

Outsourced Pharma Capabilities Update

This online event series connects biopharma companies with CDMOs to explore capabilities across biologics production, HPAPI manufacturing, and drug–device combination development. Through concise presentations, CDMOs showcase expertise in development, scale-up, containment, and GMP manufacturing. Attendees gain insights into technologies, regulatory expectations, and partnership models, while engaging directly with providers to evaluate outsourcing options and identify the best-fit partners for advancing and commercializing complex therapies. Click to learn more.